Synopsis of recent research by authors named "Linda Warnock"
Linda Warnock's research primarily focuses on evaluating the therapeutic potential and safety of antisense oligonucleotides (ASOs), exploring off-target effects, and optimizing their chemical modifications for better efficacy in treatments.
Her work also investigates the role of the p38 MAPK signaling pathway in chronic obstructive pulmonary disease (COPD), highlighting gene expression changes induced by specific inhibitors in clinical trial settings.
Additionally, she examines potential biomarkers for monitoring disease activity in rheumatoid arthritis and identifies genetic factors influencing glucocorticoid sensitivity, aiming to enhance therapeutic strategies in inflammatory diseases.
